Mabylon (private company)
See something wrong or missing? Let us know
Offices:Zurich
Industry:
Biotech
Health services
Pharma
Business model:
B2B
Mabylon is a Swiss biotech startup developing a clinical-stage lead candidate MY006 which uses human-derived antibodies to treat allergies, neurodegenerative diseases, and inflammation.
Investors:
we tracked 0 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 37.21m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom